                               SEQUENCE LISTING

<110> BOEHRINGER INGELHEIM INTERNATIONAL GMBH
 
<120> INHIBITORS OF CYTOMEGALOVIRUS

<130> 13-0181

<140>
<141>

<150> 61/722,151
<151> 2012-11-03

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
gaaggtgcag gtgccctg                                                     18


<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
gtgtcgacga acgacgtacg                                                   20


<210> 3
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe


<220>
<223> 5'-ZEN

<220>
<223> 3'-IABkFQ

<400> 3
tagacccgca tacaaa                                                       16


<210> 4
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
acccactccc tcttagccaa tatt                                              24


<210> 5
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
gtagggctag gcccaccg                                                     18


<210> 6
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe


<220>
<223> 5'-JOE

<220>
<223> 3'-IABkFQ

<400> 6
ctagtctttg ccgcctgcga agca                                              24


